AI Science Tracker

Machine-learning metabolomics distinguishes SARS-CoV-2, influenza A and RSV from respiratory swabs

British Columbia Centre for Disease Control Public Health Laboratory; University of British Columbia; Stanford University School of Medicine; Stanford Health Care; Chan Zuckerberg Biohub · 9 Oct 2025 · medicine

Discovery

Machine-learning metabolomics distinguishes SARS-CoV-2, influenza A and RSV from respiratory swabs

Untargeted metabolomics and machine learning identified upper-respiratory-swab signatures for SARS-CoV-2 positivity, followed by targeted LC-MS/MS profiling. Across 1,226 samples (521 SARS-CoV-2-positive, 97 influenza A, 96 RSV, 211 other respiratory viruses and 301 virus-negative), the best SARS-CoV-2 LightGBM model had AUC 0.99, sensitivity 0.96 and specificity 0.95. Separate models reported AUC 0.97 for influenza A and 0.99 for RSV. The top-ranked SARS-CoV-2 features included 3-oxo-heneicosanoic acid and 2-(4-hydroxyphenyl) ethanol.

Technology: Light Gradient Boosting Machine and other machine-learning classifiers applied to mass-spectrometry metabolomics

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: retrospective or benchmark
  • Tested: Separate models reported AUC 0.97 for influenza A and 0.99 for RSV.
  • Still unknown: This is an assay-validation study using stored respiratory specimens, not a prospective clinical-impact trial. Results establish classification in the studied cohorts and do not show improved patient outcomes or routine deployment. The source notes unresolved oxo-position/isomer assignment for several features. The metabolite signals are candidate host-response markers, not proof of virus-specific causal biology.
  • AI role: Machine-learning feature ranking identified metabolite signatures in untargeted profiles; the team adapted candidate signatures to targeted LC-MS/MS, and evaluated classification in respiratory-virus sample cohorts. The models supplied the sample-level classification and feature ranking, while mass spectrometry measured the metabolites.

Evidence sources: https://pubmed.ncbi.nlm.nih.gov/41065362/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: at percentile 0 of works of the same type, year and subfield (OpenAlex work metrics, 0 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.